Cargando…
Fenretinide Treatment Prevents Diet-Induced Obesity in Association With Major Alterations in Retinoid Homeostatic Gene Expression in Adipose, Liver, and Hypothalamus
The synthetic retinoid, Fenretinide (FEN), inhibits obesity and insulin resistance in mice and is in early clinical trials for treatment of insulin resistance in obese humans. We aimed to determine whether alterations in retinoic acid (RA)-responsive genes contribute to the beneficial effects of FEN...
Autores principales: | Mcilroy, George D., Delibegovic, Mirela, Owen, Carl, Stoney, Patrick N., Shearer, Kirsty D., McCaffery, Peter J., Mody, Nimesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581207/ https://www.ncbi.nlm.nih.gov/pubmed/23193184 http://dx.doi.org/10.2337/db12-0458 |
Ejemplares similares
-
Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice
por: Morrice, Nicola, et al.
Publicado: (2017) -
Fenretinide mediated retinoic acid receptor signalling and inhibition of ceramide biosynthesis regulates adipogenesis, lipid accumulation, mitochondrial function and nutrient stress signalling in adipocytes and adipose tissue
por: Mcilroy, George D., et al.
Publicado: (2016) -
The rhythm of retinoids in the brain
por: Ransom, Jemma, et al.
Publicado: (2014) -
Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR(−/−) mice
por: Thompson, Dawn, et al.
Publicado: (2023) -
Serum levels of RBP4 and adipose tissue levels of PTP1B are increased in obese men resident in northeast Scotland without associated changes in ER stress response genes
por: Hoggard, Nigel, et al.
Publicado: (2012)